Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.The ...

Merck & Co has ended a second phase 3 trial ... Pharma has not given up the hunt for new drugs for Alzheimer’s – despite the setbacks a report by ResearchersAgainstAlzheimer’s last year ...

Merck CEO Rob Davis told CNBC's Jim Cramer that ... He also pointed to Winrevair, a medicine used to treat a rare and life-threatening lung condition that was approved by the Food and Drug ...

Laura Bolognesi is leading the B2AlzD2 Joint Lab at UNIBO, with Brazilian universities to develop Alzheimer's drugs from ...